FDA Inspection
Nageshwara Arvind Dasari, MDNageshwara Arvind Dasari, MD – FDA Inspection, Nov 7, 2014
Record Details
This FDA Inspection record concerns Nageshwara Arvind Dasari, MD, with an inspection on November 7, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Nageshwara Arvind Dasari, MD
- Inspection Date
- November 7, 2014
- Product Type
- Drugs
View Company Profile
ID · 22448d84-c244-4f83-b97a-1283ecf96bc5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 902499
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60Informed consent
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Nageshwara Arvind Dasari, MD
1| Date | Classification | Office | Project area |
|---|---|---|---|
| July 20, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Nageshwara Arvind Dasari, MD
- FDA Inspection 1211294 - 2023-07-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.